Flavor houses, bioactive suppliers, and functional-ingredient teams use PIPA platforms to discover molecules, substantiate claims, and help customers formulate faster. Evidence is the new moat.

Your customers' R&D teams are getting more sophisticated. Selling an ingredient means defending its health effects, stability, and performance with primary literature — not just a spec sheet.
The molecules that matter — peptides, polyphenols, enzymes — are already in the literature. Nobody has time to find, characterize, and commercialize all of them manually.
When your customers ask 'will this work in my product?', you need an answer faster than a lab run allows. Predictive compatibility modeling turns that question into a conversation.
The capabilities ingredients R&D teams use most, and what they enable.
Connect your ingredient portfolio to bioactive compounds in scientific literature. Identify novel molecules, characterize mechanisms, and prioritize the compounds worth developing.
Build defensible ingredient evidence packages for your B2B customers. EFSA-structured health claims, FDA GRAS support, and mechanistic narratives for technical sales.
Model how your ingredient will perform in customer formulations. Compatibility, stability, sensory impact, and process behavior — predicted before they run a trial.
Predict how your ingredient survives processing and shelf life in customer environments. Reduce the diligence burden on your tech-services team.